Computational Cardiovascular Science aims at the integration of computational methods in cardiovascular research to integrate and expand the information extracted from a range of experimental and clinical data including biosignals and medical images.
Our group is part of the BHF Centre of Research Excellence at Oxford, and includes scientists based at the Department of Computer Science and the Bioengineering Institute, with strong links with the Departments of Cardiovascular Medicine and Physiology, and established collaborations with clinical and experimental collaborators in academia, hospitals, pharmaceutical companies and regulatory agencies.
Translation from basic science to clinical and industrial applications is central to our research. We are also committed to training of postdocs and graduate students in an interdisciplinary, dynamic and flexible research environment to help them acquire the necessary skills for future jobs in academia, industry or government. Our research is currently supported by the Wellcome Trust, the BHF, the European Commission, EPSRC, IMI, ARCHER and the NC3Rs. We have previously been awarded funding from the Leverhulme Trust, the Royal Society,the Royal Academy of Engineering, the MRC and the BBSRC.
We are organising the In Silico Drug Safety and Efficacy Symposium in Oxford on Sept 21-22, 2017 in the context of our NC3R Infrastructure of Impact Award and the Quantitative Systems Pharmacology Network.
We will strongly encourage presentations on all aspects of cardiotoxicity across sectors including industry, academia, hospitals and regulatory agencies.
There will be a whole day of diverse presentations and discussions followed by dinner on Sept 21st, and more activities in the morning of Sept 22nd finishing with lunch. This will enable travelling to the Safety Pharmacology Society meeting in Berlin or Computing in Cardiology in Rennes.
If you are interested, please contact us as soon as possible and preferably by May 15th with the following information:
1) Confirmation of attendance (including name, title, institution and email address)
2) If you'd like to present, tentative title.